The startup develops cloud-based medical imaging software that utilizes artificial intelligence and deep learning to analyze MRI and CT scan data. This technology enables radiologists to detect lesions more quickly and accurately, improving diagnostic efficiency in the healthcare industry.
Funding
$2.2M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
The increasing number of cancer cases and a shrinking pool of radiologists are creating a growing gap between the demand for MRI and CT scan analysis and the capacity to provide it. This can lead to delays in diagnosis and treatment, potentially impacting patient outcomes.
Solution
FUSE-AI develops AI-powered software solutions for medical image analysis, specifically targeting MRI and CT scans. Their technology aims to bridge the gap between increasing diagnostic needs and limited radiological resources by enabling faster and more accurate detection of lesions. By leveraging AI and deep learning, FUSE-AI's products assist radiologists in making informed decisions, ultimately improving the quality of patient care. The company's focus extends beyond cancer diagnostics to offer a range of AI-based health services designed to enhance efficiency, improve customer experience, and provide predictive insights for healthcare companies.
Target Audience
The primary target audience includes radiologists, healthcare providers, and pharmaceutical companies seeking to improve diagnostic accuracy, efficiency, and patient care through AI-powered medical imaging analysis.
Features
- AI-driven analysis of MRI and CT scans for lesion detection
- AI-Health Services including Chatbots, Medical Image Recognition, Regulatory Affairs, and Data Science
- Prostate.Carcinoma.ai: AI-based product for prostate cancer diagnostics
- AI-based prediction of disease progression